Navigation Links
ARUP Laboratories CEO and Co-Founder Announces Retirement
Date:4/16/2008

SALT LAKE CITY, April 16 /PRNewswire/ -- ARUP Laboratories, a national clinical and anatomic pathology reference laboratory and a leader in innovative laboratory research and development, announced today that company co-founder Carl R. Kjeldsberg, MD, will retire as chief executive officer (CEO) at the end of June 2009. Kjeldsberg has held the position since 1993 and will continue after his retirement to serve as chairman of the Board.

Effective, July 1, 2009, Edward R. Ashwood, MD, will assume the position of CEO of ARUP Laboratories. Ashwood, director of laboratories and chief medical officer, has been with ARUP for 22 years and has been a member of its executive management team for the last 12 years. He is a tenured professor of Pathology at the University of Utah School of Medicine and is board certified in clinical and chemical pathology.

"During my years at ARUP, the company has gone through an incredible amount of change. I have a great sense of pride in what our leadership team has accomplished under my tenure as CEO and I look forward to continuing to contribute to the future success as chairman of the Board," said Kjeldsberg.

"ARUP has positioned itself for the future by developing leaders who continue to drive the ongoing growth and success of our laboratory. Dr. Ashwood brings many years of experience and successful leadership to his new role at ARUP," continued Kjeldsberg.

"I am honored to have the opportunity to lead the company and further build on its past successes. Our priorities as a company will continue to center around our core strategic initiatives of supporting patients as well as our clients' existing test menus by offering highly complex tests, with accompanying consultative support, to enhance their abilities to provide local and regional laboratory services," said Ashwood. "I am very excited about the future and the opportunities that lie ahead for ARUP."

About ARUP Laboratories

ARUP Laboratories is a national clinical and anatomic pathology reference laboratory and an enterprise of the University of Utah and its Department of Pathology. With 2,100 employees, ARUP offers more than 2,000 tests and test combinations, ranging from routine screening tests to highly esoteric molecular and genetic assays, for patients throughout the country. ARUP's clients include more than half of the nation's university teaching hospitals and children's hospitals, as well as multihospital groups, major commercial laboratories, group purchasing organizations, military and government facilities, and major clinics. In addition, ARUP is a worldwide leader in innovative laboratory research and development, led by the efforts of the ARUP Institute for Clinical and Experimental Pathology(R). For more information about ARUP Laboratories, please visit http://www.aruplab.com.


'/>"/>
SOURCE ARUP Laboratories
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Vela Laboratories Receives the GMP Certificate for Its Analytical and Quality Control Laboratories
2. IDEXX Laboratories Announces First Customer Deliveries of Catalyst Dx(TM) Chemistry Analyzer and SNAPshot Dx(TM) Analyzer
3. Stonegate Report About Unigene Laboratories Inc.
4. Ardea Biosciences to Move Headquarters and R&D Laboratories to San Diego
5. White Paper Details Environmental Health & Safety Compliance Strategies for Laboratories
6. Forest Laboratories, Inc. Announces Amendment to Bystolic(TM) (nebivolol) Agreement
7. Forest Laboratories, Inc. Announces Positive Results of Memantine Study of Once-Daily Formulation
8. Clontech Laboratories, Inc. Releases the ProteoTuner(TM) Systems
9. Forest Laboratories, Inc. and Merz Pharma GmbH & Co. KgaA File Additional Lawsuit Against Several Companies for Patent Infringement
10. Alfacell Announces ONCONASE(R) Purchase and Supply Agreement with Scientific Protein Laboratories
11. Romark Laboratories Names Emmet B. Keeffe, M.D. Vice President and Chief Medical Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... ... , ... Thirty-six startup companies in University City and Center City have been ... Economic Development in 2016 as part of the Keystone Innovation Zone (KIZ) Tax Credit ... and represent the highest number of awards to the largest number of companies in ...
(Date:1/18/2017)... Jan. 18, 2017  Caris Life Sciences, a ... Foundation, the largest private funder of pancreatic cancer ... evaluating the impact of immunotherapy in the treatment ... enrollment services to identify potential trial candidates based ... treating physicians and study investigators. The Lustgarten Foundation ...
(Date:1/17/2017)... ... January 17, 2017 , ... LGC Maine Standards ... VALIDATE® SP2 calibration verification / linearity test kit. VALIDATE® SP2 evaluates Albumin, C-reactive ... SP2 kit is prepared using the CLSI recommended “equal delta” method for linearity ...
(Date:1/17/2017)... 2017  An international team of researchers from ... Boniface Hospital Albrechtsen Research Centre/University of Manitoba have ... health need affecting nearly one in 15 Americans. ... their results identify small molecule drugs with neuroprotective ... injury in animal models of metabolic, chemical and ...
Breaking Biology Technology:
(Date:1/4/2017)... , Jan. 4, 2017  CES 2017 – ... sensor technology, today announced the launch of two ... systems, the highly-accurate biometric sensor modules that incorporate ... technology, experience and expertise. The two new designs ... specifically for hearables, and Benchmark BW2.0, a 2-LED ...
(Date:12/22/2016)... 2016 SuperCom (NASDAQ:   ... the e-Government, Public Safety, HealthCare, and Finance sectors announced today that ... selected to implement and deploy a community-based supportive services program to ... , further expanding its presence in the state. ... This new program, which is ...
(Date:12/19/2016)... TORONTO , 19 de diciembre de 2016  Mosaic Biomedicals ... el desarrollo acelerado de MSC-1, un anticuerpo humanizado que se espera ... en 2017, con múltiples sitios previstos a lo largo de Europa ... MSC-1 ... factor inhibidor de leucemia (LIF), una citoquina pleiotrópica que se sobreexpresa ...
Breaking Biology News(10 mins):